Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Mar 2017

Calió Anna, Grignon David J, Stohr Bradley A, Williamson Sean R, Eble John N, Cheng Liang

Abstract excerpt

Translocation renal cell carcinoma and succinate dehydrogenase (SDH)-deficient renal cell carcinoma are now recognized as specific renal tumor types in the World Health Organization (WHO) classification. Both have limited immunohistochemical positivity for epithelial markers, and the spectrum of morphology continues to widen for both of these entities. We identified four renal cell carcinomas with positive TFE3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Basic Helix-Loop-Helix Leucine Zipper Transcription Factors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to Kidney Neoplasms

Share to Nephrectomy

Share to Succinate Dehydrogenase

Share to Translocation, Genetic

Share to Young Adult

Source

Identifiers

PMID: 27910947
DOI: 10.1038/modpathol.2016.200

Genes

SDHB
PAX8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.PMID 27910947Read ↗

The New WHO Category of “Molecularly Defined Renal Carcinomas”: Clinical and Diagnostic Features and Management ImplicationsSemantic proximity Read ↗

Genotype Phenotype Correlation of Renal Tumors in the Cancer Genome Atlas DatabaseSemantic proximity Read ↗

Succinate dehydrogenase A deficient renal cell carcinoma: A rare renal tumor distinct from typical Succinate dehydrogenase deficient renal cell carcinoma.Semantic proximity Read ↗

Genomic alterations and diagnosis of renal cancerSemantic proximity Read ↗

New Insights Into Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Comprehensive Analysis of a Case Series With Novel Mutation Sites.Semantic proximity Read ↗

Translocation carcinomas of the kidneySemantic proximity Read ↗

Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.Semantic proximity Read ↗

Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entitiesSemantic proximity Read ↗

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.Semantic proximity Read ↗

Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.Semantic proximity Read ↗

MiT family translocation renal cell carcinoma in an elderly maleSemantic proximity Read ↗

MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current KnowledgeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.